Hybrid lanthanide nanoparticles as a new class of binary contrast agents for in vivo T1/T2 dual-weighted MRI and synergistic tumor diagnosis
about
Hybrid lanthanide nanoparticles as a new class of binary contrast agents for in vivo T1/T2 dual-weighted MRI and synergistic tumor diagnosis
description
scientific article published on 05 April 2016
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2016
@uk
name
Hybrid lanthanide nanoparticle ...... nd synergistic tumor diagnosis
@en
Hybrid lanthanide nanoparticle ...... nd synergistic tumor diagnosis
@nl
type
label
Hybrid lanthanide nanoparticle ...... nd synergistic tumor diagnosis
@en
Hybrid lanthanide nanoparticle ...... nd synergistic tumor diagnosis
@nl
prefLabel
Hybrid lanthanide nanoparticle ...... nd synergistic tumor diagnosis
@en
Hybrid lanthanide nanoparticle ...... nd synergistic tumor diagnosis
@nl
P2093
P2860
P356
P1476
Hybrid lanthanide nanoparticle ...... nd synergistic tumor diagnosis
@en
P2093
Hongrong Liu
Jianhua Hao
Songjun Zeng
Xiaolong Li
P2860
P304
P356
10.1039/C5TB02375K
P407
P577
2016-04-05T00:00:00Z